openPR Logo
Press release

Artificial Intelligence: The Key To The Future Of Healthcare Market?

05-18-2022 09:06 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: MarketsandMarkets

Artificial intelligence (AI) is one of the most important technologies for the future of healthcare. It has the potential to improve patient care, reduce costs, and increase efficiency. AI has already been used to improve diagnostic accuracy in medical images, diagnose heart disease, and recommend treatments for patients with cancer.AI in healthcare market is projected to grow from USD 6.9 billion in 2021 to USD 67.4 billion by 2027, it is expected to grow at a CAGR of 46.2% from 2021 to 2027.

• Informational PDF Brochure :-
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=54679303

It is also being used to create personalized health plans and recommend treatments for chronic illnesses. AI has the potential to help doctors diagnose diseases more quickly and accurately, and to suggest treatments that are most likely to work. In the future, AI may even be able to improve our understanding of human physiology and Genetics.

View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/artificial-intelligence-healthcare-market-54679303.html

What is Artificial Intelligence?

Artificial intelligence (AI) is a subset of machine learning, which is a branch of computer science that deals with the acquisition and use of knowledge by machines. In essence, AI allows computers to "learn" on their own, making decisions based on data that was previously unavailable to them. This can be used for a wide range of purposes, fromadvancing our understanding of natural phenomena to creating digital assistants that can help us with everyday tasks.

Precision medicine is critical for two reasons: First, it allows us to identify treatments that are likely to be effective for individual patients. Second, it helps us avoid treating patients who won't benefit from the treatment or who will experience negative side effects. There are a number of ways that AI can help us achieve precision medicine in healthcare: For example, AI can help us identify biomarkers (signals that indicate the presence or progression of disease) that are relevant to a particular

How can AI benefit healthcare?

AI can help healthcare providers identify patterns and trends in patient data, making it easier to diagnose and treat patients. Additionally, AI can help doctors prescribe the right medications and treatments based on patient's symptoms. In addition, AI can help doctors provide care to more patients simultaneously by automating tasks such as billing and scheduling.

The major players in the artificial intelligence in healthcare market are Intel (US), Koninklijke Philips (Netherlands), Microsoft (US), IBM (US), Siemens Healthineers (Germany), Nvidia (US), Google (US), General Electric Company (US), Medtronic (US), Micron Technology (US), Amazon Web Services (US), Johnson & Johnson (US), General Vision (US), CloudmedX (US), Oncora Medical (US), Enlitic (US), Lunit (South Korea), Qure.ai (India), Precision Health AI (US), Cota (US), FDNA Inc. (US), Recursion Pharmaceuticals (US), Atomwise (US), Welltok (US), Babylon Health (UK), MDLIVE (Evernorth Group) (US), Gauss Surgical (US), Qventus (US), Desktop Genetics (US), Cylance (US), Ginger.io (US), and Pillo (US).

AI in healthcare: Problems it faces

Artificial intelligence has the potential to revolutionize healthcare, but it faces a number of challenges. Here are three of the biggest ones.

1) Lack of data: Healthcare is a complex system with a lot of data that needs to be processed in order to provide accurate care. Artificial intelligence doesn't have the ability to interpret all that data on its own yet, which means it needs access to more of it in order to work effectively.

2) Lack of understanding: AI can only perform certain tasks if it understands how the world works. For example, it can't diagnose a disease without knowing about the anatomy and physiology of the body. Healthcare providers need to be able to train AI using specific examples so that it can properly do its job.

3) Human error: Even with adequate training, AI can still make mistakes. This is especially true when it comes to complex tasks like diagnosing diseases. Errors can lead to incorrect diagnoses and wrong treatment plans, which can have serious consequences for patients.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Artificial Intelligence: The Key To The Future Of Healthcare Market? here

News-ID: 2627649 • Views:

More Releases from MarketsandMarkets

Research Antibodies & Reagents Market Worth $16.2 Billion | MarketsandMarkets
Research Antibodies & Reagents Market Worth $16.2 Billion | MarketsandMarkets
Research Antibodies & Reagents Market in terms of revenue was estimated to be worth $11.8 Billion in 2023 and is poised to reach $16.2 Billion by 2028, growing at a CAGR of 6.5% from 2023 to 2028 according to a new report by MarketsandMarkets™. The rise in outsourcing is a positive development for the research antibodies and reagents market. By outsourcing the development and production of antibodies and reagents, companies
Analytical Standards Market worth $2.1 billion by 2028
Analytical Standards Market worth $2.1 billion by 2028
Analytical Standards Market in terms of revenue was estimated to be worth $1.5 Billion in 2023 and is poised to reach $2.1 Billion by 2028, growing at a CAGR of 6.9% from 2023 to 2028 according to a new report by MarketsandMarkets. Factors such as growth in the applications of analytical techniques in proteomics & metabolomics and the rising public concerns related to optimal food safety & quality are high
Biopsy Devices Market worth $12.6 billion by 2028
Biopsy Devices Market worth $12.6 billion by 2028
Biopsy Devices Market in terms of revenue was estimated to be worth $6.6 billion in 2023 and is poised to reach $12.6 billion by 2028, growing at a CAGR of 14.0% from 2023 to 2028 according to a new report by MarketsandMarkets. The major factors driving the growth of this market include Progress in medical technology has resulted in the creation of increasingly accurate and less invasive biopsy instruments, thereby

More Releases for Artificial

Global Artificial Intelligence Market, Global Artificial Intelligence Industry, …
Major players in the artificial intelligence market are Google, IBM, Baidu, Microsoft, Apple Inc., Ipsoft, NVIDIA Corporation, Samsung Electronics Co.Ltd, and Micro Strategy Inc. The Global Artificial Intelligence Market is expected to grow from USD 28.42 billion in 2019 to USD 40.74 billion in 2020 at a compound annual growth rate (CAGR) of 43.39%. The growth is mainly due to the COVID-19 health emergency across the globe that has led to
Artificial Iris Market - Industry Analysis, Size, Share, Growth, Trends, and For …
The global Artificial Iris Market is anticipated to gain the market worth of US$ 16.28 million by 2025, expanding at a CAGR of 6.39% during the forecast period 2019-2025. The natural pupil controls the amount of light that enters the eye and people with pupil or iris abnormalities may experience glare or haloes in sunlight or bright artificial light. Patients may also feel self-conscious about the appearance of their eyes
Global Artificial Organs Market Facts, Figures and Analytical Insights, 2018 to …
Artificial Organs Market Introduction Artificial organ is an engineered device or tissue that is implanted into the human body. These artificial organs replace a natural organ in order to duplicate a specific function so that the patient can return to a normal life. It is a medical device with biochemical or mechanical function such as lung, heart, liver, kidney, or neurosensory organs. Artificial organs are surgically implanted or are extra
Artificial Turf Market – Sophisticated Need 2025 | Artificial Lawn, GrassTex
Global Artificial Turf Market: Overview Artificial turf has garnered much popularity over the past decades due to the powerful appeal of many of its benefits. It has become a ubiquitous part of schools, colleges, municipalities, and state government buildings. Benefits such as the need for no garnish or irrigation, easy installation, and suitability in enclosed, arched, or enclosed spaces, wherein the lack of adequate sunshine may make the maintenance of natural
Artificial Turf Market – Global Need Assumptions 2025 | Artificial Lawn, Grass …
Global Artificial Turf Market: Snapshot Growth opportunities abound in the global market for artificial turf as residential and commercial property owners increasingly focus on ways of keeping lawns green even during the rising incidences of draughts across the globe. Along with providing an easy way of conserving the water otherwise spent on keeping natural grass alive, artificial grass, or artificial turf as it is often referred to, helps eliminate the need
Artificial Organ Bank Market, Artificial Organ Bank Industry, Global Artificial …
Latest industry research report on: Global Artificial Organ Bank Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Organ necessity is surpassing the supply of donated organs. Even today there are loads of patients waiting for organ transplant but not everyone can get it done due to the low supply of organ transplant.According to the American Transplant Foundation in United States about 123,000 patients are waiting